Bone Metabolism Adjacent to Hip Prosthetic Surfaces. A Randomized Clinical F-PET/CT Study.
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Enrollment
- 32
- Locations
- 1
- Primary Endpoint
- ACETABULUM: to analyze difference in SUV of all 9 ROI's analyzed together between the two study groups (PF and TT), and to analyze SUV of all 9 ROI's analyzed together between each acetabulum prosthetic component study group and the reference group
Study Overview
Brief Summary
What is the intensity of F-PET uptake adjacent to four analyzed hip endoprosthetic components and in healthy femur and acetabulum, 1, 4 and 9 months after surgery?
Detailed Description
A clinical study of 32 patients, age 50-69 years, healthy unless osteoarthritis in one hip, randomized in two groups (16 each) plus a reference group of same 32 patient´s contralateral healthy hip.
Intervention will be surgery with a total hip arthroplasty. The four studied endoprosthetic components are:
- Cemented Exeter stem (Stryker Warsaw, USA) with a ceramic 32 mm head and Palacose cement with gentamycin, applied with 3:rd generation cementation technique.
- Uncemented Lubinus SP-CL stem (Waldemar Link, Hamburg, Germany) with a ceramic 32 mm head.
- Uncemented Delta PF cup (Limacorporate spa, Udine, Italy).
- Uncemented fibrous metal Delta TT cup (Limacorporate spa, Udine, Italy). Both cups will have cross linked Ultra-high-molecular-weight polyethylene (UHWMP).
Clinical score, radiography and uptake of Fluoride tracer will be analyzed.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 50 Years to 69 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •patients diagnosed to have unilateral hip osteo arthritis verified by radiography (Charnley group A) aimed for THA at Gävle hospital and accepting to participate in the study.
Exclusion Criteria
- •any systemic disease (other than osteo arthritis) or medication affecting skeleton methabolism
Arms & Interventions
Exeter femur component and Delta TT acetabular component
Intervention: Surgery for Total Hip Arthroplasty (THA) (Device)
SP-CL femur component and Delta TT acetabular component
Intervention: Surgery for Total Hip Arthroplasty (THA) (Device)
SP-CL femoral component and Delta PF acetabular component
Intervention: Surgery for Total Hip Arthroplasty (THA) (Device)
Exeter femoral component and Delta PF acetabular component
Intervention: Surgery for Total Hip Arthroplasty (THA) (Device)
Outcomes
Primary Outcomes
ACETABULUM: to analyze difference in SUV of all 9 ROI's analyzed together between the two study groups (PF and TT), and to analyze SUV of all 9 ROI's analyzed together between each acetabulum prosthetic component study group and the reference group
Time Frame: 1 months after surgery
There are two study groups for acetabulum: two models of uncemented acetabular prosthetic components. There is also an acetabular reference group.
FEMUR: to analyze difference in SUV of the 4 upper ROI's (No 1, 7, 8 and 13) analyzed together between the two study groups AND: to analyze SUV of the 4 upper ROI's analyzed together between each femur study group and the reference group
Time Frame: 1 months after surgery
There are two study groups for femur: cemented and uncemented femur prosthetic components. There is also a femur reference group.
Secondary Outcomes
- FEMUR:to analyze difference in SUV for each individual ROI inbetween the cemented and uncemented femur group(1, 4 and 9 months aftyer surgery)
- FEMUR:to analyze difference in SUV for the 4 upper ROI's (No 1, 7, 8 and 13) analyzed together between the 2 study groups(4 and 9 months aftyer surgery)
- ACETABULUM: to analyze difference in SUV for each individual ROI between the two study groups. To analyze difference in SUV for each individual ROI between each of the two study groups and the reference group.(1, 4 and 9 months aftyer surgery)
- ACETABULUM: to analyze difference in SUV for each individual ROI for the Delta PF study group between the 3 time points. To analyze difference in SUV for each individual ROI for the Delta TT study group between the 3 time points.(1, 4 and 9 months aftyer surgery)
- FEMUR:to analyze difference in SUV for the 4 upper ROI's analyzed together between each study group and the reference group(4 and 9 months aftyer surgery)
- ACETABULUM: to analyze difference in SUV for each individual ROI between the 2 study groups(1, 4 and 9 months aftyer surgery)
- FEMUR: to analyze difference in SUV for each individual ROI between the cemented study group and the reference group. To analyze difference in SUV for each individual ROI between the uncemented study group and the reference group.(1, 4 and 9 months aftyer surgery)
- ACETABULUM: to analyze SUV of all 9 ROI's analyzed together between each acetabulum study group and the reference group(4 and 9 months)
- FEMUR:to analyze difference in SUV for each individual ROI between the 3 time points for the cemented group. To analyze difference in SUV for each individual ROI between the 3 time points for the uncemented group.(1, 4 and 9 months aftyer surgery)
- ACETABULUM: to analyze difference in SUV of all 9 ROI's analyzed together between the two acetabular study groups(4 and 9 months aftyer surgery)
Investigators
gosta ullmark
Assistent Professor
Uppsala University